Contact Supplier

Contact Supplier

To get in touch with Xzencis AB, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .

    Xzencis to share Translational Safety insights at EUROTOX congress in Copenhagen

    news-releasesXzencis AB
    August 9th 2024

    Mölnlycke, Sweden: – Translational Safety and pharmacovigilance specialist consultancy Xzencis will be present at the upcoming 58th Congress of European Societies of Toxicology, EUROTOX, in the Danish capital of Copenhagen.

    The company’s founder and Managing Director, Dr. Steffen Ernst will attend the conference to hear of latest trends and developments in toxicology and drug safety.

    Knowledge sharing on Translational Safety

    Dr. Ernst will participate in the numerous networking events during the four-day meeting, which is focused on ‘Toxicology – A Quest for safe Chemicals and Medicines’.

    He will be sharing his specialist insights on the Translational Safety approach to toxicology in clinical and postlaunch product development, showing how a seamless, uninterrupted, and objective-driven methodology can deliver significant therapeutic gains, as well as moral and commercial ones.

    About Xzencis AB

    Xzencis provides a wide suite of expert consultancy services focused on Translational Safety Solutions: planning and executing transitions and problem solving along the entire pharmaceutical value chain from pre-clinical target to market launch and beyond.

    The company’s strength is based on in-depth subject matter expertise in medicinal regulation, toxicology, clinical Patient Safety (PS) and Pharmacovigilance (PV), business administration, business development and licensing uniquely combined with hands-on business experience. These allow us to assist any life sciences company or organization with safety and regulatory issues, such as strategy development and execution, pre-clinical and clinical challenges, inbound or outbound licensing, building safety value chains, governance, Due Diligence assessments for investors and organizational design of safety departments.

    Where extra personnel are required, Xzencis can call on an extensive network of senior, experienced Toxicologists, NCDS sub-discipline experts, Safety Physicians, Safety Scientists and PV Systems experts; all with tested and proven, impeccable track records.

    Learn more at: www.xzencis.com

    About EUROTOX 2024

    EUROTOX is the Annual Congress of the European Societies of Toxicology and takes place each year in a different city of Europe. The meetings are dedicated to furthering interdisciplinary collaboration on toxicology within the medical industries and knowledge sharing on the newest aspects of modern toxicology and methodologies.

    The 58th Annual Congress, EUROTOX 2024, will be a four-day event, opening September 8 at Copenhagen’s striking Kim Utzon-designed Tivoli Congress Center at its waterside location in the center of the Danish capital.

    The 2024 meeting is themed ‘Toxicology – A Quest for safe Chemicals and Medicines’, with a  program stressing safety of drugs and environmental chemicals, new and emerging technologies, personalized medicine, human health effects caused by exposure to chemicals as well as safety issues arising from climate change.

    The event is organised by the Danish Society of Toxicology & Pharmacology, with further information at: https://www.eurotox2024.com

    COST EFFICIENT EXPERT CONSULTANCY

    Cost efficient consultants at Xzencis manage pharmaceutical product development with a focus on a integrated safety strategy with defined objectives along the pre-clinical and clinical safety value chain, saving you in the long run

    FREE DOWNLOAD
    Xzencis to share Translational Safety insights at EUROTOX congress in Copenhagen
    Xzencis to share Translational Safety insights at EUROTOX congress in Copenhagen

    EUROTOX 2024 venue: Tivoli Congress Center, Copenhagen.

     

    Contact Xzencis AB

    Simply fill out the form below to contact Xzencis AB now.

    Send Xzencis AB a Message